Production (Stage)
Pharming Group N.V.
PHAR
$11.86
$0.64775.78%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 167.89M | 160.32M | 201.97M | 213.42M | |
| Total Receivables | 50.17M | 51.12M | 38.70M | 42.62M | |
| Inventory | 55.72M | 59.19M | 55.88M | 56.76M | |
| Prepaid Expenses | 4.65M | -- | -- | 3.54M | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 278.44M | 270.63M | 296.55M | 316.34M | |
|
|
|||||
| Total Current Assets | 278.44M | 270.63M | 296.55M | 316.34M | |
| Net Property, Plant & Equipment | 24.13M | 30.72M | 31.86M | 33.47M | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | 61.04M | 66.57M | 68.30M | 71.27M | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 32.14M | 40.64M | 37.28M | 31.38M | |
| Total Assets | 399.99M | 415.93M | 441.67M | 462.85M | |
|
|
|||||
| Total Accounts Payable | 10.10M | 72.97M | 68.52M | 16.02M | |
| Total Accrued Expenses | 53.22M | -- | -- | 50.27M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 7.19M | 6.97M | 138.77M | 5.44M | |
| Total Finance Division Other Current Liabilities | 3.28M | -- | -- | 6.23M | |
| Total Other Current Liabilities | 3.28M | -- | -- | 6.23M | |
| Total Current Liabilities | 73.80M | 79.94M | 207.29M | 77.97M | |
|
|
|||||
| Total Current Liabilities | 73.80M | 79.94M | 207.29M | 77.97M | |
| Long-Term Debt | 78.15M | 87.32M | -- | 136.60M | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 26.97M | 27.73M | 28.44M | 29.51M | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 178.92M | 194.99M | 235.72M | 244.07M | |
|
|
|||||
| Common Stock & APIC | 496.76M | 494.60M | 487.34M | 486.10M | |
| Retained Earnings | -287.92M | -273.66M | -558.79M | -265.50M | |
| Treasury Stock & Other | 12.23M | -- | -4.00M | -1.82M | |
| Total Common Equity | 221.06M | 220.94M | 205.95M | 218.78M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 221.06M | 220.94M | 205.95M | 218.78M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 221.06M | 220.94M | 205.95M | 218.78M | |
|
|
|||||